Validity and Reliability of the Assessment of Burden of Chronic Conditions Scale in the Netherlands

Danny Claessens; Esther A. Boudewijns; Lotte C. E. M. Keijsers; Annerika H. M. Gidding-Slok; Bjorn Winkens; Onno C. P. van Schayck

doi:10.1370/afm.2954

Published eLetters

If you would like to comment on this article, click on Submit a Response to This article, below. We welcome your input.

Submit a Response to This Article

Compose eLetter

Title *

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. higgs-boson@gmail.com Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

What code is in the image? *

Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

RE: Validity and Reliability of the Assessment of Burden of Chronic Conditions Scale in the Netherlands
David Damjanoski and Lorraine S Wallace

Published on: 19 November 2023

Published on: (19 November 2023)
Page navigation anchor for RE: Validity and Reliability of the Assessment of Burden of Chronic Conditions Scale in the Netherlands
RE: Validity and Reliability of the Assessment of Burden of Chronic Conditions Scale in the Netherlands
David Damjanoski, Medical student, SS Cyril and Methodius University—Faculty of Medicine
Other Contributors:
Lorraine S Wallace, Associate Professor—College of Medicine
Asthma, chronic obstructive pulmonary disease (COPD), and type 2 diabetes (T2D) are commonly seen in primary care practice. As healthcare advances and those with chronic diseases live longer, recognizing the impact of patient disease burden through use of a validated tool such as the Assessment of Burden of Chronic Conditions (ABCC) scale is critical in delivering comprehensive care.

The (ABCC) scale is of great importance to help physicians better understand their patients' state when their disease is under control. I found it very interesting that the ABCC is reliable in patients living with both asthma and COPD simultaneously. This has led me to the question–would the ABCC tool be valid and reliable in patients with connected multi-comorbidities such as in diabetics who have lost their sight due to diabetic retinopathy, diabetics with chronic kidney disease undergoing dialysis as well as diabetics with advanced atherosclerosis? With diabetes and its complications on the rise, demand for an advanced ABCC is becoming very important. Having this in mind, are the authors planning a follow-up study with patients with multi-comorbidities?

Finally, smoking is a significant and ongoing problem in developing countries and especially the Balkans, such as my homeland North Macedonia. Given that most households have multiple smokers, would the authors consider adding a second-hand smoke exposure question, in the lifestyle section, if it were to be translated into...
Show More

Asthma, chronic obstructive pulmonary disease (COPD), and type 2 diabetes (T2D) are commonly seen in primary care practice. As healthcare advances and those with chronic diseases live longer, recognizing the impact of patient disease burden through use of a validated tool such as the Assessment of Burden of Chronic Conditions (ABCC) scale is critical in delivering comprehensive care.

The (ABCC) scale is of great importance to help physicians better understand their patients' state when their disease is under control. I found it very interesting that the ABCC is reliable in patients living with both asthma and COPD simultaneously. This has led me to the question–would the ABCC tool be valid and reliable in patients with connected multi-comorbidities such as in diabetics who have lost their sight due to diabetic retinopathy, diabetics with chronic kidney disease undergoing dialysis as well as diabetics with advanced atherosclerosis? With diabetes and its complications on the rise, demand for an advanced ABCC is becoming very important. Having this in mind, are the authors planning a follow-up study with patients with multi-comorbidities?

Finally, smoking is a significant and ongoing problem in developing countries and especially the Balkans, such as my homeland North Macedonia. Given that most households have multiple smokers, would the authors consider adding a second-hand smoke exposure question, in the lifestyle section, if it were to be translated into Macedonian?
Show Less

Competing Interests: None declared.